PROACTIVE IMMUNE RECOGNIZED AS A TOP 5 FINALIST
at the Washington Technology Industry Association's First Look Forum, in November, 2014.
FIND OUT MORE
• OUR TECHNOLOGY •
Immune cell therapy is one of the fastest growing and most promising areas of treatment for cancer and other immune system diseases. Proactive Immune Sciences is founded on the technology of cellular cryopreservation using vapor phase liquid nitrogen, which keeps immune cells viable for decades, and the belief that banking younger, healthier personal immune cells can provide our clients with a chance for better outcomes should they become immunocompromised later in life due to cancer or other immune-related disorders.
Harnessing the immune system to battle tumours was declared 2013’s “Breakthrough of the Year” by Science, the flagship journal of the American Association for the Advancement of Science.